Cidara Therapeutics Inc (CDTX) Downgraded by Zacks Investment Research to Hold

Cidara Therapeutics Inc (CDTX) Downgraded by Zacks Investment Research to Hold


According to Zacks, "Cidara Therapeutics, Inc. is a biotechnology company. The company is focused on the discovery, development and commercialization of novel anti-infectives.



from Biotech News